Results 171 to 180 of about 39,918 (251)

Comment on “Apixaban removal during emergency surgery for type a acute aortic dissection: a prospective cohort study”

Shixue Zhang
openalex   +1 more source

Reducing complexity and burden of anticoagulant management in patients with cancer-associated venous thromboembolism. [PDF]

Haematologica
Brenner B.
europepmc   +1 more source

Economic Evaluation of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparin for Cancer-Associated Thrombosis in a Thai University-Affiliated Hospital. [PDF]

J Clin Med
Chaiwattanakowit T, Pinitpracharome N, Dilokthornsakul W, Akrawikrai T, Dilokthornsakul P.   +4 more
europepmc   +1 more source

More light at the end of the tunnel – apixaban in atrial fibrillation [PDF]

, 2012
Sheila A Doggrell
openalex   +1 more source

Multicenter Evaluation of Different Anti-Xa Assays and Diluted Russell's Viper Venom Time in Ex Vivo Plasma Samples from Patients Treated with Rivaroxaban or Apixaban. [PDF]

J Clin Med
Božič Mijovski M, Mavri A, Antovic JP, Malmström RE, Coen Herak D.   +4 more
europepmc   +1 more source

Comparison of apixaban 5 mg vs 2.5 mg for the prevention of cancer-associated venous thromboembolism: A pooled analysis of two studies [PDF]

Michael Sabina, Vikas Malhotra, Shivangi Patel, Jennifer Trube, ZACHARY BRESLOW, Joseph M. Massaro, Anas Bizanti   +6 more
openalex   +1 more source

Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report. [PDF]

Am J Case Rep
Babonji A, Algethmi FA, Almutairi BS, Alsulami A, Al-Mrzouki AF.   +4 more
europepmc   +1 more source

Predictors of Direct Oral Anticoagulant Use in Northern Italy: A Population-Based Study. [PDF]

Pharmacoepidemiol Drug Saf
Ojeda-Fernández L, Agostini G, Zanovello A, Prada P, Fortino I, Augurio C, Baviera M.   +6 more
europepmc   +1 more source

Case Report: Apixaban induced spontaneous muscular hematoma in a patient with inclusion body myositis

Francis Sto. Domingo, Antonio Gutiérrez, Mrudula Thiriveedi, Siddharth Patel, Rafik ElBeblawy   +4 more
openalex   +1 more source

Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease. [PDF]

Eur Heart J Cardiovasc Pharmacother
Dari L, Beradid S, Constans J, Pariente A, Renoux C.   +4 more
europepmc   +1 more source